Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Gastroenterology & Hepatology|July 10, 2012
Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse modelFemke Heindryckx, Eliene Bogaerts, Stephanie H Coulon, et al.
Molecular Cancer|August 24, 2010
Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinomaFemke Heindryckx, Koen Mertens, Nicolas Charette, et al.
Biology Direct|April 26, 2026
Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro modelsTania Payo-Serafín, Carolina Méndez-Blanco, Jennifer Martínez-Geijo, et al.
Plos One|March 21, 2015
Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumorsEliene Bogaerts, Femke Heindryckx, Lindsey Devisscher, et al.
The Journal of Biological Chemistry|July 26, 2013
MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA)Zsolt Kasza, Peder Fredlund Fuchs, Christoffer Tamm, et al.
Cytokine|June 5, 2012
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver diseaseStephanie Coulon, Sven Francque, Isabelle Colle, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent modelsStephanie Coulon, Vanessa Legry, Femke Heindryckx, et al.
Molecular Metabolism|November 29, 2023
Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cellsMaria Kopsida, Ada Lerma Clavero, Jaafar Khaled, et al.
Plos One|September 13, 2016
Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic CholangiopathiesJan Best, Stefaan Verhulst, Wing-Kin Syn, et al.
BMJ Open|November 7, 2022
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survivalSofi Sennefelt Nyman, Håkan Ahlström, Angeliki Dimopoulou Creusen, et al.
Pageof 6